These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 14995004

  • 1. Mycophenolate mofetil combined with prednisone for diffuse proliferative lupus nephritis: a histopathological study.
    Ding L, Zhao M, Zou W, Liu Y, Wang H.
    Lupus; 2004; 13(2):113-8. PubMed ID: 14995004
    [Abstract] [Full Text] [Related]

  • 2. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
    Arends S, Berden JH, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Dutch Working Party on SLE.
    Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
    [Abstract] [Full Text] [Related]

  • 3. Distinct effects of mycophenolate mofetil and cyclophosphamide on renal fibrosis in NZBWF1/J mice.
    Yung S, Zhang Q, Chau MK, Chan TM.
    Autoimmunity; 2015 Nov; 48(7):471-87. PubMed ID: 26099989
    [Abstract] [Full Text] [Related]

  • 4. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
    Ong LM, Hooi LS, Lim TO, Goh BL, Ahmad G, Ghazalli R, Teo SM, Wong HS, Tan SY, Shaariah W, Tan CC, Morad Z.
    Nephrology (Carlton); 2005 Oct; 10(5):504-10. PubMed ID: 16221103
    [Abstract] [Full Text] [Related]

  • 5. Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis.
    Kasitanon N, Fine DM, Haas M, Magder LS, Petri M.
    Lupus; 2006 Oct; 15(6):366-70. PubMed ID: 16830883
    [Abstract] [Full Text] [Related]

  • 6. Lupus nephritis: treatment with mycophenolate mofetil.
    Kapitsinou PP, Boletis JN, Skopouli FN, Boki KA, Moutsopoulos HM.
    Rheumatology (Oxford); 2004 Mar; 43(3):377-80. PubMed ID: 14963204
    [Abstract] [Full Text] [Related]

  • 7. [Mycophenolate mofetil maintenance therapy in lupus nephritis].
    Milewski M, Jakieła B, Zółciński M, Chmielewska A, Musiał J.
    Pol Arch Med Wewn; 2006 Oct; 116(4):947-54. PubMed ID: 18416296
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
    Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A.
    J Rheumatol; 2001 Sep; 28(9):2103-8. PubMed ID: 11550982
    [Abstract] [Full Text] [Related]

  • 9. Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial.
    Stoenoiu MS, Aydin S, Tektonidou M, Ravelingien I, le Guern V, Fiehn C, Remy P, Delahousse M, Petera P, Quémeneur T, Vasconcelos C, D'Cruz D, Gilboe IM, Jadoul M, Karras A, Depresseux G, Guillevin L, Cervera R, Cosyns JP, Houssiau FA, MAINTAIN Nephritis Trial Group.
    Nephrol Dial Transplant; 2012 May; 27(5):1924-30. PubMed ID: 22110048
    [Abstract] [Full Text] [Related]

  • 10. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
    F L, Y T, X P, L W, H W, Z S, H Z, Z H, MMF in Induction Therapy for Active Lupus Nephritis in Mainland China Study Group.
    Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sequential therapies for proliferative lupus nephritis.
    Contreras G, Pardo V, Leclercq B, Lenz O, Tozman E, O'Nan P, Roth D.
    N Engl J Med; 2004 Mar 04; 350(10):971-80. PubMed ID: 14999109
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of lupus nephritis by mycophenolate mofetil.
    Rabrenović V, Poskurica M, Kovacević Z, Nesić V, Savin M, Mitić B, Dimković N, Cucković C, Vujić D, Pljesa S, Perunicić-Peković G, Curić S, Mitić I, Ratković M, Marinković J, Jovanović D.
    Kidney Blood Press Res; 2010 Mar 04; 33(4):297-303. PubMed ID: 20664209
    [Abstract] [Full Text] [Related]

  • 15. Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid.
    Yung S, Zhang Q, Zhang CZ, Chan KW, Lui SL, Chan TM.
    Arthritis Rheum; 2009 Jul 04; 60(7):2071-82. PubMed ID: 19565476
    [Abstract] [Full Text] [Related]

  • 16. Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study.
    Boletis JN, Marinaki S, Skalioti C, Lionaki SS, Iniotaki A, Sfikakis PP.
    Nephrol Dial Transplant; 2009 Jul 04; 24(7):2157-60. PubMed ID: 19179411
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of class V+IV lupus nephritis with multitarget therapy.
    Bao H, Liu ZH, Xie HL, Hu WX, Zhang HT, Li LS.
    J Am Soc Nephrol; 2008 Oct 04; 19(10):2001-10. PubMed ID: 18596121
    [Abstract] [Full Text] [Related]

  • 18. The safety and efficacy of MMF in lupus nephritis: a pilot study.
    Kingdon EJ, McLean AG, Psimenou E, Davenport A, Powis SH, Sweny P, Burns A.
    Lupus; 2001 Oct 04; 10(9):606-11. PubMed ID: 11678448
    [Abstract] [Full Text] [Related]

  • 19. Central nervous system lymphoma associated with mycophenolate mofetil in lupus nephritis.
    Dasgupta N, Gelber AC, Racke F, Fine DM.
    Lupus; 2005 Oct 04; 14(11):910-3. PubMed ID: 16335585
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM, Sahin S, Kiziltas S, Masatlioglu S, Oguz F, Ergin H.
    Ren Fail; 2008 Oct 04; 30(9):865-9. PubMed ID: 18925525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.